Alembic Pharmaceuticals Limited (Alembic), a vertically integrated research and development pharmaceutical company, announced that it has received final approval from the US Food & Drug Administration ...
The company has incorporated Alembic Pharmaceuticals (Thailand) Co., Ltd. as a subsidiary entity in Thailand. The new company has an authorised share capital of Baht 3,000,000, divided into 300,000 ...
Alembic Pharmaceuticals has received U.S. Food and Drug Administration final approval for its abbreviated new drug application for Carbidopa, Levodopa and Entacapone Tablets in different strengths.
Alembic Pharma (ALPM) exhibited in-line revenue with a slight miss on EBITDA/PAT for the quarter. While ex-US export growth was strong for the quarter, it was offset by moderate YoY growth in domestic ...
Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals on Thursday reported lower third‑quarter profit on Thursday after taking a one-time charge linked to India's new labour code, despite strong ...
Fintel reports that on January 15, 2026, Alembic Global initiated coverage of ATI (NYSE:ATI) with a Overweight recommendation. Analyst Price Forecast Suggests 1.04% Downside As of January 14, 2026, ...
Led by Prysm Capital and Accenture with participation from Silver Lake Waterman, Liquid 2 Ventures, NextEquity, Friends & Family Capital, and WndrCo, this round positions Alembic among the top AI labs ...
Alembic Technologies raises $145M and buys an Nvidia-powered supercomputer to accelerate ‘causal AI’
Causal artificial intelligence startup Alembic Technologies Inc. said today it has raised $145 million in a Series B growth round that increases its valuation almost 16-fold. It’s using a big chunk of ...
Alembic Technologies has raised $145 million in Series B and growth funding at a valuation 15 times higher than its previous round, betting that the next competitive advantage in artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results